Crossmark

Facilitating a culture of responsible and effective sharing of cancer genome data

Crossref DOI link: https://doi.org/10.1038/nm.4089

Published Online: 2016-05-05

Published Print: 2016-05

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Siu, Lillian L

Lawler, Mark

Haussler, David

Knoppers, Bartha Maria

Lewin, Jeremy

Vis, Daniel J

Liao, Rachel G

Andre, Fabrice

Banks, Ian

Barrett, J Carl

Caldas, Carlos

Camargo, Anamaria Aranha

Fitzgerald, Rebecca C

Mao, Mao

Mattison, John E

Pao, William

Sellers, William R https://orcid.org/0000-0003-2604-2498
Sullivan, Patrick

Teh, Bin Tean

Ward, Robyn L

ZenKlusen, Jean Claude

Sawyers, Charles L

Voest, Emile E
License Information

Text and Data Mining valid from 2016-05-01
More Information

Article History

Received: 21 November 2015

Accepted: 21 March 2016

First Online: 5 May 2016

Competing interests

: J.C.B. is employed by AstraZeneca and is a stock owner of AstraZeneca. W.P. is employed by Roche, is a shareholder of Roche, has rights to EGFR T790M mutation testing (licensed to MolecularMD) and is a co-founder of MyCancerGenome. W.R.S. is employed by the Novartis Institute for Biomedical Research and is a shareholder of Novartis Pharma. C.L.S. serves on the Board of Novartis Pharma. All other authors declare no competing financial interests.